Literature DB >> 22368184

The hazards of interrupting anticoagulation therapy in atrial fibrillation.

Stefan H Hohnloser, John W Eikelboom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22368184     DOI： 10.1093/eurheartj/ehs032

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  4 in total

1.  A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation.

Authors:  Miney Paquette; Daniel M Witt; Anne Holbrook; Jane Skov; Jack Ansell; Holger J Schünemann; Wojtek Wiercioch; Robby Nieuwlaat
Journal:  Blood Adv       Date:  2019-05-28

2.  Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation.

Authors:  Xiaoxi Yao; Neena S Abraham; G Caleb Alexander; William Crown; Victor M Montori; Lindsey R Sangaralingham; Bernard J Gersh; Nilay D Shah; Peter A Noseworthy
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

3.  Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach.

Authors:  Carmen Suárez Fernández; Suárez Fernández; Francesc Formiga; Miguel Camafort; María Cepeda Rodrigo; Jose Cepeda Rodrigo; Jesús Díez-Manglano; Antonio Pose Reino; Pose Reino; Gregorio Tiberio; Jose María Mostaza
Journal:  BMC Cardiovasc Disord       Date:  2015-11-04       Impact factor: 2.298

4.  Discontinuation of non-Vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: a population-based cohort study using primary care data from The Health Improvement Network in the UK.

Authors:  Ana Ruigómez; Pareen Vora; Yanina Balabanova; Gunnar Brobert; Luke Roberts; Samuel Fatoba; Oscar Fernandez; Luis Alberto García Rodríguez
Journal:  BMJ Open       Date:  2019-10-18       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.